Bleichroeder Acquisition Corp. III 8-K

What Happened
Bleichroeder Acquisition Corp. III announced on July 8, 2026 that it closed its initial public offering of 34,500,000 units at $10.00 per unit, generating gross proceeds of $345,000,000 (including full exercise of a 4,500,000‑unit over‑allotment). Each Unit consists of one Class A ordinary share and one‑quarter of a warrant; each full warrant allows the holder to purchase one Class A share at $11.50. The company also completed private sales of 8,500,000 warrants at $1.00 per warrant to its Sponsor and the underwriters. Key corporate governance steps were taken in connection with the offering, including filing amended and restated constitutional documents and appointing two directors.

Key Details

• IPO: 34,500,000 units sold at $10.00/unit; gross proceeds $345,000,000 (includes 4,500,000 over‑allotment). Closing date: July 8, 2026.
• Warrants: Public units include 8,625,000 public warrants (34,500,000 × 1/4); 8,500,000 Private Placement Warrants sold (Sponsor 5,000,000; underwriters 3,500,000) at $1 each. Warrant exercise price: $11.50/share.
• Trust account: $345,000,000 placed in a U.S. trust (held for initial business combination or shareholder redemptions); interest may be released only for taxes and winding‑up expenses. The trust funds include up to $14.7M of the underwriters’ deferred discount.
• Governance and agreements: Clemence Rasigni and Christopher Kellen were appointed to the Board (both to Audit and Compensation Committees; Rasigni chairs Audit, Kellen chairs Compensation). The company executed its underwriting, warrant, registration rights, private placement and other offering‑related agreements and filed amended constitutional documents effective July 6, 2026.

Why It Matters
This filing confirms Bleichroeder Acquisition Corp. III has completed its SPAC IPO and has cash parked in a trust account to pursue an initial business combination (subject to the company’s 24‑month deadline and shareholder redemption rights). Retail investors should note the amount held in trust, the large number of warrants outstanding (public + private), and the warrant exercise price, all of which affect potential future dilution and timing of any transaction. The newly appointed directors and indemnity arrangements reflect the governance changes made for the company’s public life.